Peripheral Neuropathy as a Result of Cancer
Peripheral neuropathy is a neurological condition involving damage to the peripheral nerves—the nerves outside of the brain and spinal cord. Unfortunately, ten to 20 percent of cancer patients develop peripheral neuropathy during their course of treatment. While peripheral neuropathy adds an additional strain to a cancer patient's treatment and recovery, the American Society of Clinical Oncology notes that “many people recover fully from the disorder over time, whether it is in a few months or a few years.”
Link to Cancer
Not every cancer patient will develop peripheral neuropathy. The American Society of Clinical Oncology states that patients with lung cancer, breast cancer, ovarian cancer, prostate cancer, multiple myeloma and Hodgkin lymphoma have the greatest risk, due to the treatment options. The largest cause of peripheral neuropathy secondary to cancer is the chemotherapy drugs. In large doses, these drugs can damage the peripheral nerves:
--Bortezomib
--Platinums (cisplatin, oxaliplatin and carboplatin)
--Taxanes (docetaxel and paclitaxel)
--Thalidomide
We value and respect the experiences of all of our HerWriters, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice although we hope you can gain knowledge from their insight.
Add A New CommentComments
There are no comments yet. Be the first to get the conversation started.